Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/08/2003EP1350508A1 Antifungal formulation and the methods for manufacturing and using the same
10/08/2003EP1350507A1 Delivery of a substance to a pre-determinated site
10/08/2003EP1349578A2 Medicinal association of a biguanine (metformin) and arginine
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349554A2 Compositions and methods for treating an arthritic condition
10/08/2003EP1349549A2 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides
10/08/2003EP1349545A1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
10/08/2003EP1349543A1 Method for producing tablets from plant extracts
10/08/2003EP1349541A1 Self emulsifying lipid matrix (selm)
10/08/2003EP1349540A2 Topical alcoholic solution of a salicylic acid derivative and acemannan
10/08/2003EP1349531A1 Spaced drug delivery system
10/08/2003EP1272230B1 Injectable bone mineral substitute material comprising bone cement and oil
10/08/2003EP1183014B1 Controlled release and taste masking oral pharmaceutical compositions
10/08/2003EP1165119B1 Composition based on oppositely-charged polypeptides
10/08/2003EP1140018B1 Polyol/oil suspensions for the sustained release of proteins
10/08/2003EP1137398B1 Pharmaceutical preparation for inhalation of an opioid
10/08/2003EP0819010B1 Protein formulation comprising coagulation factor viii or factor ix in an aqueous sucrose solution
10/08/2003CN1447792A Aporphine esters and their use in therapy
10/08/2003CN1447699A Peptide and peptide minetic conjugates with integrin-inhibitor properties
10/08/2003CN1447698A Flavone-contg. plant extract solutions having improved storage and head stability
10/08/2003CN1447694A Rapid onset formulation
10/08/2003CN1447684A Stable gabapentin having PH within controlled range
10/08/2003CN1447683A Polymeric micelle compsns.
10/08/2003CN1447682A Amphotericin B structured emulsion
10/08/2003CN1447681A Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn.
10/08/2003CN1447680A Topical micronutrient delivery system and uses thereof
10/08/2003CN1446838A Hydrophilic polymer-combo of silybum mariamum extract product as well as medicinal combination containing the combo
10/08/2003CN1446833A Warm sensitivity degradable micro gelatin and its preparation method
10/08/2003CN1446809A Derivant of new type sweetsop lactone as well as preparation method and usage
10/08/2003CN1446591A Injectable solidifying on site cement with inorganic framework and application in micro traumatic treatment
10/08/2003CN1446585A Combination object of half solid framework preparation of gingko leaf extract product
10/08/2003CN1446584A Addition agent of pyrithioxine hydrochloride utilized for injection
10/08/2003CN1446581A Coupling object between CB and biological active peptide or immunoglobhulin or immunological activity original as well as medication usage
10/08/2003CN1446542A Compound preparation for preventing and treating typical model pneumonia and other virus infection diseases
10/08/2003CN1446540A Combination of semisolid framework preparation of progesterone
10/08/2003CN1446536A Combination of semisolid framework preparation of nimodipine
10/08/2003CN1446535A Chlorhydric [R(2)-alpha-methoxyimindogen-alpha-(1-dicycloaza [2.2.2] caryl-3-group) acetonitrile control-released dosage form
10/08/2003CN1123343C Nicotine compsns. and method for formulation thereof
10/08/2003CN1123338C Pharmaceutical formulation of omeprazole
10/08/2003CN1123337C Liquid aqueous pharmaceutical compsns. comprising sodium alginate and potassium bicarbonate
10/08/2003CA2424683A1 Hla matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/07/2003US6631283 B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging
10/07/2003US6630588 Dye labeled imidazoquinoline compounds
10/07/2003US6630576 Mutated forms of hIL13 conjugated to cytotoxins are used to preferentially target diseased cells over non-diseased cells
10/07/2003US6630511 Water-soluble salts of 2-difluoromethyl-2,5-diaminopentanoic acid (DFMO)
10/07/2003US6630486 Containing calcium sulfate
10/07/2003US6630460 Adduct of heparin and polyoxyalkylene glycol; coating medical equipment
10/07/2003US6630459 Immunoisolation of a cell; use of biomedically pure, p-GlcNAc of high molecular weight and consistent properties.
10/07/2003US6630457 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630445 Unglycosylated recombinant human alpha-fetoprotein made in a prokaryote (e.g., E. coli)
10/07/2003US6630310 Assay for binding between carbohydrate and glycolipid
10/07/2003US6630171 Polypeptide polymers of aspartic acid and glutamic acid bearing a hydrophobic group; drug delivery; insulin carrier
10/07/2003US6630168 Dimethylacetamide in combination with methyl cellulose, hydroxypropyl methylcellulose, or carboxypolymethylene; intralesional administering
10/07/2003US6630165 For sustained release; therapy
10/07/2003US6630161 Stable oil in water emulsion; vaccine; squalene, PLURONIC, egg phosphatidyl choline, glycerol, alpha tocopherol
10/07/2003US6630155 Thermoplastic base polymer, a solvent, a poly(lactide-co-glycolide)/polyethylene glycol block polymer
10/07/2003US6630151 Addition of a long chain carboxylic acid thickener in cosmetics and pharmaceuticals;
10/07/2003US6630150 Microcrystalline cellulose, an oily substance, surfactant, and water; capsule or tablet solid dosage forms; oil in water emulsion
10/07/2003US6630129 Pharmaceutical formulation of fluticasone propionate
10/07/2003US6630120 Co-administering intravascularly a bradykinin agonist that increases the transport of said substance from the bloodstream to the internal spaces of said non-central nervous system solid tumor
10/07/2003US6629995 Camptothecin conjugates
10/07/2003US6629968 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
10/07/2003US6629964 Steam generating unit comprising steam generating part using chemical energy, moisture permeable sheet, and temperature regulating material in between; releases steam from surface applied to skin or mucous membrane at 50 degrees C. or less
10/07/2003US6629835 Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2
10/07/2003CA2373821C Topical compositions for prostaglandin e1 delivery
10/07/2003CA2362508C Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
10/07/2003CA2241288C Pseudoephedrine hydrochloride extended release tablets
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/07/2003CA2212803C Redispersible nanoparticulate film matrices with protective overcoats
10/07/2003CA2207286C Localized delivery of factors enhancing survival of transplanted cells
10/07/2003CA2162854C Method for treating neurological disorders
10/07/2003CA2124821C Novel solid pharmaceutical dispersions
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080665A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003WO2003080629A2 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080181A2 Storage stable eplerenone formulation
10/02/2003WO2003080121A1 Macromolecular compounds as potential anti-inflammatory agents
10/02/2003WO2003080120A1 Test system for evaluating the compatibility of biologically active substances with copolymers
10/02/2003WO2003080117A1 Methods for treating chronic obstructive pulmonary disease (copd)
10/02/2003WO2003080115A1 Immunoglobulin/hydrophilic peptide complexes
10/02/2003WO2003080108A1 Stable pharmaceutical composition containing factor viii
10/02/2003WO2003080107A1 Remedies for protozoan diseases
10/02/2003WO2003080090A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450
10/02/2003WO2003080082A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
10/02/2003WO2003080079A1 Use of sulfoalkyl ether cyclodextrin as a preservative
10/02/2003WO2003080056A2 Fine particle size pioglitazone
10/02/2003WO2003080051A1 Method of treating onychomycosis
10/02/2003WO2003080040A1 Diclofenac sodium oral pharmaceutical
10/02/2003WO2003080035A1 Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
10/02/2003WO2003080032A2 Pharmaceutical formulation for the active ingredient budesonide
10/02/2003WO2003080031A1 Sustained release formulation of tramadol
10/02/2003WO2003080029A1 No-donating nsaids adsorbed into carrier particles
10/02/2003WO2003080027A1 Nanoparticulate compositions of angiogenesis inhibitors
10/02/2003WO2003080025A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/02/2003WO2003080024A2 Nanoparticulate compositions of map kinase inhibitors
10/02/2003WO2003080023A2 Fast dissolving dosage forms having reduced friability
10/02/2003WO2003080022A2 Analgesics for nasal administration
1 ... 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 ... 1712